3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
COVID-19
1
Interventions
BNT162 Vaccine
1
2019-nCoV Vaccine mRNA-1273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
COVID-19
×
2019-nCoV Vaccine mRNA-1273
×
Clear all
NCT05075538
2024-01-17
I-SPARC
Jules Bordet Institute
Phase 4
Terminated
152 enrolled